SCHEMBL9894750

SCHEMBL9894750

CO/C=C(\C(=O)OC)c1ccccc1COc1cc(/C(C)=N/O)ccc1OC

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.48
HDAC8 Q9BY41 3/20 0.46
SMPD1 P17405 2/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
CHEK1 O14757 1/20 0.38
PIM1 P11309 1/20 0.38
MAPK8 P45983 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9894755 1.00 HIF1A (0.48) HIF1AHDAC8SMPD1HDAC1HDAC6
SCHEMBL9894752 1.00 HIF1A (0.48) HIF1AHDAC8SMPD1HDAC1HDAC6
SCHEMBL9894824 0.96 HIF1A (0.44) HIF1AHDAC8ALDH1A1MAPTSMN1; SMN2
SCHEMBL9894822 0.96 HIF1A (0.44) HIF1AHDAC8ALDH1A1MAPTSMN1; SMN2
SCHEMBL9894821 0.96 HIF1A (0.44) HIF1AHDAC8ALDH1A1MAPTSMN1; SMN2
SCHEMBL9894754 0.92 HIF1A (0.50) HIF1AHDAC8SMPD1HDAC1HDAC6
SCHEMBL9894823 0.88 HIF1A (0.46) HIF1AHDAC8ALDH1A1MAPTSMN1; SMN2
SCHEMBL9895554 0.88 MAPT (0.50) HIF1AHDAC8SMPD1HDAC1HDAC6
SCHEMBL9895555 0.88 MAPT (0.50) HIF1AHDAC8SMPD1HDAC1HDAC6
SCHEMBL9895558 0.88 MAPT (0.50) HIF1AHDAC8SMPD1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772290-B2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same Oscotech Inc. (KR) 2014-07-08 US claimed
EP-2565180-A2 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Oscotec Inc. (KR) 2013-03-06 EP claimed
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME OSCOTEC INC. (KR) 2012-06-14 US claimed
US-8772290-B2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same Oscotech Inc. (KR) 2014-07-08 US disclosed
EP-2565180-A2 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Oscotec Inc. (KR) 2013-03-06 EP disclosed
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME OSCOTEC INC. (KR) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME HIF1A, HIF1AN, EGLN3 HIF1A 1/4885HDAC8 3396/4885SMPD1 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.